Tytuł pozycji:
Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)
-
Tytuł:
-
Lapatinib with ECF/X in the first-line treatment of metastatic gastric cancer according to HER2neu and EGFR status: a randomized placebo-controlled phase II study (EORTC 40071)
-
Autorzy:
-
Moehler, MarkusAff1, Aff9
Schad, Arno
Maderer, Annett
Atasoy, Ajlan
Mauer, Murielle E.
Caballero, Carmela
Thomaidis, Thomas
John, Jestinah M. Mahachie
Lang, Istvan
Van Cutsem, Eric
Freire, João
Lutz, Manfred P.
Roth, Arnaud
the EORTC Gastrointestinal Tract Cancer Group
-
Źródło:
-
Cancer Chemotherapy and Pharmacology. 82(4):733-739
-